sponsored byAAAS Golden Fund

EurekAlert!, a service of AAAS
Home About us
Advanced Search
22-May-2015 19:50
US Eastern Time

Username:

Password:

Register

Forgot Password?

Press Releases

Breaking News

Science Business

Grants, Awards, Books

Meetings

Multimedia

Science Agencies
on EurekAlert!

US Department of Energy

US National Institutes of Health

US National Science Foundation

Calendar

Submit a Calendar Item

Subscribe/Sponsor

Links & Resources

Portals

RSS Feeds

Accessibility Option On

Options

Portal Home

Glossary

Background Articles

Research Papers

Meetings

Links & Resources

Disease in the Developing World

News Releases

Key: Meeting M      Journal J      Funder F

Showing releases 101-125 out of 1032.

<< < 1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 > >>

Public Release: 1-Apr-2015
New England Journal of Medicine
Experimental Ebola vaccine safe, prompts immune response
An early-stage clinical trial of an experimental Ebola vaccine conducted at the National Institutes of Health and the Walter Reed Army Institute of Research found that the vaccine, called VSV-ZEBOV, was safe and elicited robust antibody responses in all 40 of the healthy adults who received it.
NIH/National Institute of Allergy and Infectious Diseases

Contact: Anne A. Oplinger
aoplinger@niaid.nih.gov
301-402-1663
NIH/National Institute of Allergy and Infectious Diseases

Public Release: 1-Apr-2015
New England Journal of Medicine
VSV-EBOV Ebola vaccine appears safe and generates immune response
An experimental Ebola vaccine called VSV-EBOV appears safe and elicited a robust immune response in a small phase 1 clinical trial, according to findings to be published in the New England Journal of Medicine on April 2, 2015. Two independent but coordinated studies, performed at the Walter Reed Army Institute of Research and the National Institute of Allergy and Infectious Diseases, explored the safety and immunogenicity of the investigational vaccine when administered at different dosages.
NIH/National Institute of Allergy and Infectious Diseases, NIH/National Cancer Institute,Defense Threat Reduction Agency, Joint Vaccine Acquisition Program

Contact: Dr. Debra Yourick
debra.l.yourick.civ@mail.mil
301-319-9471
US Army Medical Research Institute of Infectious Diseases

Public Release: 1-Apr-2015
Global Heart
Barriers found that prevent Ugandans with RHD from receiving needed penicillin
Access to penicillin can prevent deaths from rheumatic heart disease. Researchers from Case Western Reserve University, Makerere University and the Uganda Heart Institute at Mulago Hospital, a national referral hospital in Kampala, collaborated to learn about obstacles that prevent people from receiving the medication and find ways to overcome them.
The Arnold P. Gold Foundation

Contact: Susan Griffith
susan.griffith@case.edu
216-368-1004
Case Western Reserve University

Public Release: 1-Apr-2015
Lancet Global Health
Simpler antibiotic treatments could help millions of infants who lack access to hospitals
Giving fewer antibiotic injections to young infants in the developing world with severe infections such as pneumonia and sepsis is just as safe and effective as the standard course of twice daily injections over the course of a week, according to new Johns Hopkins School of Public Health research conducted in Bangladesh.
United States Agency for International Development, Bill & Melinda Gates Foundation

Contact: Brandon Howard
brandonhoward@jhu.edu
410-502-9059
Johns Hopkins University Bloomberg School of Public Health

Public Release: 31-Mar-2015
Journal of Public Health Management and Practice
How did he do it? Mayor Bloomberg's public health strategy evaluated in Journal of Public Health Management and Practice
How did former New York City Mayor Michael Bloomberg succeed in achieving so much of his 'comprehensive and far-reaching' public health agenda? Key strategies included harnessing the full authority of the City health department and mobilizing the existing workforce to focus on targeted reforms, according to a study in the March/April issue of the Journal of Public Health Management and Practice. The journal is published by Wolters Kluwer.

Contact: Connie Hughes
Connie.Hughes@wolterskluwer.com
646-674-6348
Wolters Kluwer Health

Public Release: 31-Mar-2015
Nature Communications
Pig-borne disease most likely jumped into humans when rearing practices changed
The most virulent strains of Streptococcus suis, the leading cause of bacterial meningitis in adult humans in parts of southeast Asia and in pigs around the world, are likely to have evolved and become widespread in pigs at the same time as changes in rearing practices, according to research from an international consortium published today in the journal Nature Communications.
Biotechnology and Biological Sciences Research Council

Contact: Craig Brierley
craig.brierley@admin.cam.ac.uk
44-012-237-66205
University of Cambridge

Public Release: 31-Mar-2015
Proceedings of the Royal Society B
Faulty modeling studies led to overstated predictions of Ebola outbreak
Frequently used approaches to understanding and forecasting emerging epidemics -- including the West African Ebola outbreak -- can lead to big errors that mask their own presence, according to a University of Michigan ecologist and his colleagues.

Contact: Jim Erickson
ericksn@umich.edu
734-647-1842
University of Michigan

Public Release: 31-Mar-2015
Bulletin of the World Health Organization
Study -- Governments can prevent tragic death toll of mothers and babies
'Inequities in postnatal care in low- and middle-income countries: a systematic review and meta-analysis' is by Étienne V. Langlois, Malgorzata Miszkurka, Maria Victoria Zunzunegui, Abdul Ghaffar, Daniela Zieglerc & Igor Karp.

Contact: Fiona Fleck
fleckf@who.int
41-227-911-897
Bulletin of the World Health Organization

Public Release: 30-Mar-2015
Journal of Clinical Investigation
Blood-based biomarkers could enable simple, accurate TB tests for diagnosis and monitoring
Researchers have identified blood-based biomarkers in patients with active tuberculosis that could lead to new blood-based diagnostics and tools for monitoring treatment response and cure.
National Institutes of Health, Emory Center for AIDS Research, Emory Global Health Institute, Yerkes National Primate Research Center

Contact: Holly Korschun
hkorsch@emory.edu
404-727-3990
Emory Health Sciences

Public Release: 27-Mar-2015
NYU developing HIV antibodies and RNA test in a single POC
NYU College of Dentistry has received a sub-award in the amount of $335,000 from a Small Business Innovation Research (SBIR) Phase II grant from NIH to complete the development of a fully automated self-confirming assay that can simultaneously detect HIV/AIDS antibodies and viral RNA from the AIDS virus in a single specimen.
NIH/Small Business Innovation Research Phase II Grant

Contact: Christopher James
christopher.james@nyu.edu
212-998-6876
New York University

Public Release: 27-Mar-2015
Lancet
Research on medical abortion and miscarriage may change international routines
Two scientific studies led by researchers at Sweden's Karolinska Institutet are expected to form the basis of new international recommendations for the treatment of medical abortions and miscarriages. Both studies are being published in the journal 'The Lancet'.
Swedish Research Council, Karolinska Institutet, Stockholm County Council, Dalarna University, World Health Organization

Contact: KI Press Office
pressinfo@ki.se
46-852-486-077
Karolinska Institutet

Public Release: 26-Mar-2015
Ebola test vaccines appear safe in phase 2 Liberian clinical trial
Two experimental Ebola vaccines appear to be safe based on evaluation in more than 600 people in Liberia who participated in the first stage of the Partnership for Research on Ebola Vaccines in Liberia Phase 2/3 clinical trial, according to interim findings from an independent Data and Safety Monitoring Board review. Based on these findings, the study, which is sponsored by the NIAID, part of the National Institutes of Health, may now advance to Phase 3 testing.
NIH/National Institute of Allergy and Infectious Diseases

Contact: Jennifer Routh
Jennifer.routh@nih.gov
301-402-1663
NIH/National Institute of Allergy and Infectious Diseases

Public Release: 26-Mar-2015
Cell Reports
Researchers master gene editing technique in mosquito that transmits deadly diseases
Rockefeller University researchers have successfully harnessed a technique, CRISPR-Cas9 editing, to use in an important and understudied species: the mosquito, Aedes aegypti, which infects hundreds of millions of people annually with the deadly diseases chikungunya, yellow fever, and dengue fever.
NIH/National Institute of Allergy and Infectious Diseases, NIH/National Center for Advancing Translational Sciences, NIH/National Institutes of Health Clinical and Translational Science Award, Jane Coffin Childs Fund, Howard Hughes Medical Institute

Contact: Zach Veilleux
zveilleux@rockefeller.edu
212-327-8982
Rockefeller University

Public Release: 26-Mar-2015
New England Journal of Medicine
Chikungunya virus may be coming to a city near you -- learn the facts
The mosquito-borne chikungunya disease is predicted to soon spread to the US The University of Texas Medical Branch at Galveston's Scott Weaver, globally recognized for his expertise in mosquito-borne diseases, has been studying chikungunya for more than 15 years. Weaver and fellow infectious disease expert Marc Lecuit of the Institut Pasteur have summarized currently available information on this disease in the March 26 edition of the New England Journal of Medicine.

Contact: Donna Ramirez
donna.ramirez@utmb.edu
409-772-8791
University of Texas Medical Branch at Galveston

Public Release: 26-Mar-2015
mBio
How the human immune system keeps TB at bay
A new tissue culture model using human white blood cells shows how people with a latent -- or symptom-free -- tuberculosis infection are protected from active disease by a critical early step in their immune response, researchers say.

Contact: Larry Schlesinger
Larry.Schlesinger@osumc.edu
614-292-8789
Ohio State University

Public Release: 26-Mar-2015
Scientists secure £25.7 million to create powerhouse of research
A £25.7 million funding boost will enable the University of Edinburgh to set up two world-leading laboratories advancing biological research and tissue repair.
UK Research Partnership Investment Fund

Contact: Jen Middleton
jen.middleton@ed.ac.uk
44-131-650-6514
University of Edinburgh

Public Release: 26-Mar-2015
Journal of Allergy and Clinical Immunology
A metabolic imbalance increases the risk of respiratory diseases in childhood
An imbalance in our metabolism can trigger inflammatory processes in the body and activate the immune system. In a recent study, published in the Journal of Allergy and Clinical Immunology, UFZ researchers have been able to show that this applies even to newborns and children under one year of age, and is correlated with the development of respiratory diseases in early childhood.
Helmholtz Association

Contact: Gunda Herberth
gunda.herberth@ufz.de
49-034-123-51547
Helmholtz Centre for Environmental Research - UFZ

Public Release: 26-Mar-2015
Cochrane Library
Effect of natural sweetener Xylitol in preventing tooth decay still unproven
New research out today concludes that there is limited evidence to show that xylitol is effective in preventing dental cavities in children and adults.

Contact: Evelyn Martinez
sciencenewsroom@wiley.com
Wiley

Public Release: 26-Mar-2015
PLOS Neglected Tropical Diseases
International collaboration essential in fight against rabies, new study finds
A new study, published today in the journal PloS Neglected Tropical Diseases has given new insights into the spread of rabies in the Middle East, showing that the deadly disease regularly moves between countries in the region.

Contact: Peter La
p.la@surrey.ac.uk
0044-148-368-9191
University of Surrey

Public Release: 26-Mar-2015
Science
Ebola whole virus vaccine shown effective, safe in primates
An Ebola whole virus vaccine, constructed using a novel experimental platform, has been shown to effectively protect monkeys exposed to the often fatal virus. The vaccine, described today in the journal Science, was developed by a group led by Yoshihiro Kawaoka, a University of Wisconsin-Madison expert on avian influenza, Ebola and other viruses of medical importance.
National Institutes of Health, Japanese Health and Labour Sciences Research Grants

Contact: Yoshihiro Kawaoka
kawaokay@svm.vetmed.wisc.edu
University of Wisconsin-Madison

Public Release: 26-Mar-2015
Report: Budget cuts undermine global health innovations protecting against threats like Ebola
As the world looks to American innovation to fight Ebola, malaria, tuberculosis, and a host of other health threats, a new report released today on Capitol Hill warns budget battles in Washington are eroding preparedness at home and abroad at a time when scientific advances are poised to deliver new lifesaving drugs, vaccines, and diagnostics.

Contact: Katy Lenard
klenard@burness.com
301-280-5719
Burness Communications

Public Release: 25-Mar-2015
New England Journal of Medicine
Ebola more deadly for young children
Ebola progresses more quickly and is more likely to be fatal for children under five, according to new research.
Medical Research Council, Bill and Melinda Gates Foundation, National Institutes of Health, NIH/National Institute for Health Research, Wellcome Trust, EU PREDEMICS, Fogarty International Center

Contact: Sam Wong
sam.wong@imperial.ac.uk
44-207-594-2198
Imperial College London

Public Release: 24-Mar-2015
Journal of Bone and Mineral Research
Good bone, bad bone
Until now, doctors have been able to measure bone loss -- a process that happens slowly, over time -- but haven't had the means for gauging actual bone strength.

Contact: Julie Cohen
julie.cohen@ucsb.edu
805-893-7220
University of California - Santa Barbara

Public Release: 24-Mar-2015
PLOS Genetics
Genetic discovery may offer new avenue of attack against schistosomiasis
Researchers have discovered a group of genes in one species of snail that provide a natural resistance to the flatworm parasite that causes schistosomiasis, and opens the door to possible new drugs or ways to break the transmission cycle of this debilitating disease. It's been called a neglected global pandemic.
National Institutes of Health

Contact: Michael Blouin
blouinm@science.oregonstate.edu
541-737-2362
Oregon State University

Public Release: 24-Mar-2015
Disaster Medicine and Public Health Preparedness
Quarantine yes/no?
The decision to quarantine individuals or groups during epidemics is not an exact science and is open to various interpretations. Providing guiding principles, the authors suggest the need to balance public safety with human rights.

Contact: Alice O'Donnell
dmphpjournal@gmail.com
240-833-4429
Society for Disaster Medicine and Public Health

Showing releases 101-125 out of 1032.

<< < 1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 > >>